EGFR and neoplasm: Meanwhile, Doxy@CaCO3-PEG-activated Tet-HER1-CAR-T exhibited better antitumor efficacy than conventional HER1-CAR-T cells, though Doxy@CaCO3-PEG itself exhibited a minimal tumor-suppression effect (Fig. S17A).